NHS

News

Towards a new understanding of cardiovascular risk in diabetes

NICE unlocks use of Amarin's Vazkepa in 425k NHS patients

Health technology assessment (HTA) agency NICE has finalised its guidance on Amarin's Vazkepa, clearing the path for GPs to start prescribing the drug in up to 425,000 NHS patients at high

News

Radiology technician examens mammography test on location

NICE backs two new breast cancer drugs for NHS use

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

News

BMS' Opdivo gets NHS use as adjuvant bladder cancer therapy

NICE has recommended routine use of Bristol-Myers Squibb's Opdivo for the adjuvant treatment of some patients with urothelial carcinoma (UC), the most common form of bladder cancer.

News

NHS England trials first medicine deliveries by drone

Cancer drugs will be flown from a facility in Portsmouth to a hospital on the Isle of Wight by drone, in the first pilot study of the technology by NHS England.

R&D

The post-Covid New Normal: a golden opportunity for the NHS?

I recently had the pleasure of attending the PING Conference 2022, which had the tagline of ‘

News

UK health secretary Sajid Javid in shock resignation

UK health secretary Sajid Javid is giving up his position after a year in the role, saying in his resignation letter that he can "no longer, in good conscience, continue serving in this gov

NICE unlocks use of Amarin's Vazkepa in 425k NHS patients

NICE backs two new breast cancer drugs for NHS use

BMS' Opdivo gets NHS use as adjuvant bladder cancer therapy

NHS England trials first medicine deliveries by drone

The post-Covid New Normal: a golden opportunity for the NHS?

UK health secretary Sajid Javid in shock resignation

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

NHS

Editor's Picks